Financial performance of Beximco

Pharmaceuticals Limited
The Presenters…….

Asif Mahmud Onik ID : 141051002

Umma Tamanna ID : 141051074

Bithi Athter ID : 133051065

Joyel Hamid Patowary ID : 133051081

Tahiatul Jannat ID : 133051030

General Information of Beximco Pharmaceutical Ltd

Part of the Beximco Group of Companies.

The most trusted partner in Healthcare.

The Company’s state-of-the-art manufacturing facilities

are certified.
Become one of Bangladesh's leading pharmaceutical
companies.
Beximco Pharmaceutical Ltd
 Mission: We are committed to enhancing human health and
well being by providing contemporary.
 Vision: We will be one of the most trusted, admired and
successful pharmaceutical companies in the region.
 Core values: 1. Commitment to quality

2. Customer satisfaction
 Income Statement of Beximco Pharmaceuticals Ltd
Details Amount in Taka

Year
2012 2011
Net Sales Revenue 9,289,115,284 7,890,241,843
Less: Cost of Goods Sold (4,899,713,857) (4,103,709,021)
Gross Profit 4,389,401,427 3,786,532,822
Less: Operating Expenses
Administrative Expenses (332,225,347) (275,201,846)
Selling, Marketing and Distribution Expenses (1,849,296,520) (1,522,851,278)
Total Operating Expenses (2,181,521,867) (1,798,053,124)
Profit from Operations 2,207,879,560 1,988,479,698

Add: Other Income 442,847,713 340,907,774

Less: Finance Cost (645,406,575) (1,522,851,278)
Profit before Contribution to W P P& Welfare Funds 2,005,320,698 1,761,741,715
Less: Contribution to W P P& Welfare Funds (95,491,462) (83,892,463)
Profit Before Tax 1,909,829,236 1,677,849,252
Less: Income Tax Expenses
Current Tax (445,712,907) (207,549,905)
Deferred Tax (144,727,001) (271,774,005)
Total Income Tax Expenses (590,439,908) (479,323,910)
Profit after Tax for the Year 1,319,389,328 1,198,525,342
Add: Other Comprehensive Income - -
Total Comprehensive Income for the Year 1,319,389,328 1,198,525,342
Owner’s Equity Statement of Beximco Pharma Limited

Details Amount in Taka

Balance as on January 01, 2012 17,128,128,177

Add: Total Comprehensive Income for 2012

Profit for the Year 2012 1,319,389,328

Less: Adjustment for Deferred Tax on Revalued Assets (39,355,646)

Balance as on December 31, 2012 18,408,161,859

Details Amount in Taka
ASSETS Year 2012 Year 2011
Non-Current Assets
Property, Plant and Equipment- Carrying Value 16,201,858,216 15,745,492,625
Intangible Assets 187,079,147 135,933,879
Investment in Shares 3,451,276 3,451,276
Total Non-Current Assets 16,392,388,639 15,884,877,780
Current Assets
Inventories 2,433,987,981 2,291,844,631
Spares & Supplies 396,175,790 325,881,244
Accounts Receivable 1,162,404,807 978,224,317
Loans, Advances and Deposits 965,276,373 840,320,705
Short Term Investment 2,686,598,326 2,193,423,560
Cash and Cash Equivalents 552,978,676 518,768,296
Total Current Assets 8,197,421,953 7,148,462,753
Total Assets 24,589,810,592 23,033,340,533
EQUITY AND LIABILITIES
Shareholders’ Equity
Issued Share Capital 3,046,390,500 2,517,678,100
Share Premium 5,269,474,690 5,269,474,690
Excess of Issue Price over Face Value of GDRs 1,689,636,958 1,689,636,958
Capital Reserve on Merger 294,950,950 294,950,950
Revaluation Surplus 1,406,527,880 1,466,602,600
Retained Earnings 6,701,180,881 5,889,784,879
Total Shareholders’ Equity 18,408,161,859 17,128,128,177
Non-Current Liabilities
LongTerm Borrowings-Net off Current Maturity (Secured) 1,469,621,611 1,890,074,651
Liability for Gratuity & WPPF 499,622,784 403,598,795
Deferred Tax Liability 1,147,459,569 963,376,922
Total Non-Current Liabilities 3,116,703,964 3,257,050,368
Current Liabilities and Provisions
Short Term Borrowings 1,526,449,918 1,642,216,008
Long Term Borrowings-Current Maturity 664,712,728 363,744,181
Creditors and Other Payables 470,097,685 523,798,136
Accrued Expenses 128,598,961 101,559,917
Dividend Payable 1,020,948 1,361,452
Income Tax Payable 274,064,529 15,482,294
Total Current Liabilities and Provisions 3,064,944,769 2,648,161,988
TOTAL EQUITY AND LIABILITIES 24,589,810,592 23,033,340,533
 Data Presentation and Analysis of Beximco
Pharmaceuticals Limited

The result can be analyzed in three ways that perfectly emphasis us to know
the overall performance of BPL. The Ways are

 Profitability

 Liquidity

 Efficiency
 Profitability of BPL:
Ratio Analysis & comparison for the year
Sl Details Year 2012 Year 2011
1. Mark up = (Gross Profit X (4,389,401,427 X 100)/ (3,786,532,822 X100)/
100)/ Cost of Goods Sold. 4,899,713,857 = 89.58 4,103,709,021 = 92.27

2. Margin or gross profit (4,389401,427 X (3,786,532,822

percentage = (Gross profit X 100)/9,289,115,284 = 47.25 X100)/7,890,241,843 = 47.99
100)/ Net Sales
3. Net Profit to sales ratio or net (1,319,389,328 X 100)/ (1,198,525,342 X 100)/
profit percentage = (Net Profit 9,289,115,284 =14.20 7,890,241,843 = 15.18
X 100)/ Net Sales
4. Return on capital employed = (1,319,389,328 X 100)/ (1,198,525,342 X
(Net profit X 100)/Capital 1,776,814,5018 = 7.42 100)/17,128,128,177 = 6.99
employed
5. Return on capital invested = (1,319,389,328 X 100)/ (1,198,525,342 X
Net profit X 100)/Owner’s 18,408,161,859 = 7.16 100)/17,128,128,177 = 6.99
Capital
 Liquidity of BPL:
Sl No Details Year 2012 Year 2011

1. Current Ratio = 8,197,421,953: 7,148,462,753:

Current Assets : 3,064,944,769 = 2.67:1 2,648,161,988 = 2.70
Current Liabilities
2. Acid test ratio/Quick
5,763,433,972:3,064,9 4,856,618,122:2,648,1
ratio = Current
44,769 = 1.88 61,988 = 1.83
assets less stock or
inventory : Current
Liabilities
 Efficiency of BPL:

Sl No Details Year 2012 Year 2011

1. Stock Turn Over = 4,899,713,857/2,433,987, 4,103,709,021/2,291,844,631

Cost of goods 981 = 2.013 = 1.79
sold/average stock
 Comparison of Income Statement for the year

12,000,000,000

10,000,000,000

8,000,000,000

6,000,000,000

4,000,000,000

2,000,000,000

0
e d it s s s s s e t s s ax s ax ax s r e r
nu S ol rof se se se se i on om os nd nd T se T T se ea om ea
e P n n n n t c C u u n t n Y c Y
v s e e e e
er
a In ce F F re e n d e e In he
Re od oss xp xp xp xp p r n re re efo xp rre erre xp r th e rt
s o r E E E E O h e n a lf a l f a B E u ef E o i v o
le
-2,000,000,000 G G g e n g t i e e it x C D x f s f
Sa t of a t in a t iv u t io a t in rom :O s :F W W rof Ta Ta ax h en m
e
t s r t r b r f d s & & P e e T e o
Ne Co pe is tri pe f it Ad Le P P om om fte
r pr In
c
: : O in D is l O ro P P nc nc a m e
ss m P I o
ss Ad d ta W W
s: lI of
it
rC si
v
Le Le an To to to s ota
Pr e e n
-4,000,000,000 g n n Le T th h
etin u t io u t io : O p re
k rib rib d m
M
ar nt nt Ad Co
o o l
g, C C
ot
a
ll in o re s s: T
-6,000,000,000 f
Se be Le
f it
o
Pr
Representing Net Income for the year 2012
Net Sales Revenue
Less: Cost of Goods Sold
Gross Profit
Less: Operating Expenses
Administrative Expenses
Selling, Marketing and
Distribution Expenses
Total Operating Expenses
Profit from Operations

Add: Other Income

Less: Finance Cost
Profit before Contribution to
W P P& Welfare Funds
Less: Contribution to W P P&
Welfare Funds
Profit Before Tax
Less: Income Tax Expenses
Current Tax
Deferred Tax
Total Income Tax Expenses
Profit after Tax for the Year
Add: Other Comprehensive
Income
 Comparison of Gross Profit for the year

2012 2011

9,289,115,284
7,890,241,843

4,389,401,427
3,786,532,822

-4,103,709,021

Net Sales Revenue Less: Cost of Goods Sold Gross Profit

-4,899,713,857
 Comparison of Net Profit for the year
1400000000
1,319,389,328

1,198,525,342
1200000000

1000000000

800000000 Add: Other

Comprehensive Income
600000000

Total Comprehensive
400000000
Income for the Year

200000000

2012 2011
 Comparison of Financial Position for the year
2012 & 2011
30000000000

25000000000

20000000000

15000000000

10000000000

5000000000

0
ts e ts s ts ts s s le ts t ts ts ts S ty al m s r s s ty s ) F ty s s s ty s s le le s S
sse Valu sse hare sse sse orie plie vab osi men len sse sse LITIE qui apit iu GDR erge rplu ning qui ilitie ured PP bili ilitie sion ing turi able ense yab yab sion LITIE
t m i w i
t A g e A S t A t A en up cei ep est iva t A l A BI ’ E C re of M Su ar ’ E iab ec W Lia iab ov ro a ay xp Pa Pa ov BI
r en ryin gibl nt in ren ren Inv & S Re nd D Inv Equ ren ota LIA ders are re P lue on on ed E ders nt L y (S ity & Tax nt L Pr Bor nt M er P d E nd Tax Pr LIA
ur ar n e ur ur es ts a m h ur T ND hol d Sh ha Va rve uati ain hol rre urit atu ed rre and rm rre th rue ide e and ND
-C t- C Inta stm n-C C ar oun ces Ter Cas al C S ce se al et re u at Gr rr u s e u d O cc iv om s
n e o p
S cc an rt d ot Y A are sue a Re ev R ha n-C M r efe n-C itie rt T s-C an A D Inc itie ITY
A
No men v
In al N A dv ho an T IT h Is F
r l R o l g il U
EQ
U S
ve pita l S o nt f D l No iabi Sho win ors iab L EQ
ui
p
Tot s, A S ash o a o ta N rre ility ta L o it L
q ice C T Cu ab t rr ed nt A
E an C
ff Li To ren re TOT
and Lo Pr o r Bo Cr r
t ue et Cu rm Cu
P lan f Iss s-N g Te tal
, so ng n To
erty ces owi Lo
op Ex rr
Pr Bo
rm
gTe
n
Lo
Comparison of Ratio Analysis for the year
Year 2012 Year 2011

92.27
89.58

47.25 47.99

14.2 15.18

7.42 6.99 7.16 6.99

Thank you